GGrantIndex
← Leaderboards

Thomas Jefferson University

Philadelphia, PA

Compare ↔
$1,730,409,376
Total funding
1,671
Grants

Funding over time

peak $92.3M · FY2005–25
$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$1,661,542,493 · 1562
DOD$54,915,574 · 77
NSF$4,866,171 · 13
AHRQ$4,709,602 · 12
NASA$2,159,507 · 2
DOE$1,856,845 · 3
CDC$388,075 · 1
USDA$82,796 · 1
SAMHSA$0 · 1

By mechanism

R01$1,165,860,141 · 699
R21$90,779,453 · 236
—$63,880,893 · 96
P30$59,408,839 · 107
U01$44,918,519 · 21
T32$41,337,917 · 21

Investigators at Thomas Jefferson University

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Pawan Sharma$1,889,7141 gr2Marco Tigano$1,802,0501 gr3Rajarshi Chakrabarti$1,170,0001 gr4Mahdi Alizadeh$1,141,1921 gr5Fadia Fayez Ibrahim$1,079,8501 gr6Hien T. Dang$1,061,3711 gr7Anjali Mishra$1,052,7081 gr8Monika Pogorzelska-Maziarz$722,2161 gr

Emerging Leaders

6–10 yrs in

1Kristin Laura Rising$5,188,9853 gr2Yajing Wang$4,879,4564 gr3Erin Seifert$4,749,1085 gr4Lin Guo$4,061,0003 gr5Kibo Nam$3,822,5203 gr6Jun He$3,606,5094 gr7Sangwon Vincent Kim$3,591,4534 gr8Anna Pluciennik$3,326,2664 gr

All-Time

Most funded here, all years

1Abdolmohamad Rostami$24,176,24813 gr2Gyorgy Hajnoczky$23,648,45016 gr3Carlo M Croce$22,969,16910 gr4Jay S Schneider$21,748,79710 gr5Laura N. Gitlin$21,135,58112 gr6Ya-Ming Hou$21,058,42318 gr7Luis J. Sigal$20,924,79313 gr8Richard Fishel$20,511,12810 gr

Largest grants

Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever$6,784,550
N01 · FY2019 · AI
Jefferson Alumni Hall 3 West Lab Modernization$6,651,849
C06 · FY2010 · RR
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever$4,833,059
N01 · FY2018 · AI
TRANSLATIONAL RESEARCH IN CANCER$4,827,378
P30 · FY2003 · CA
TRANSLATIONAL RESEARCH IN CANCER$4,520,018
P30 · FY2005 · CA
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever$4,515,928
N01 · FY2020 · AI
TRANSLATIONAL RESEARCH IN CANCER$4,440,350
P30 · FY2006 · CA
TRANSLATIONAL RESEARCH IN CANCER$4,385,601
P30 · FY2002 · CA
TRANSLATIONAL RESEARCH IN CANCER$4,358,919
P30 · FY2004 · CA
TRANSLATIONAL RESEARCH IN CANCER$4,309,306
P30 · FY2007 · CA
TRANSLATIONAL RESEARCH IN CANCER$4,220,081
P30 · FY2001 · CA
Exosome-mediated propagation of disease linked poly-dipeptides in C9orf72-FTD/ALS$3,560,090
RF1 · FY2018 · AG
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever$3,413,667
N01 · FY2022 · AI
Advanced Development of a Multivalent Vaccine Candidate for Lassa Fever$3,347,060
N01 · FY2025 · AI
NOVEL TUMOR-TARGETED IMMUNOTHERAPIES AGAINST METASTATIC UVEAL MELANOMA$3,120,000
· FY2025 · Defense Health Agency
Translational Research in Cancer$3,116,058
P30 · FY2008 · CA
Translational Research in Cancer$3,107,901
P30 · FY2024 · CA
Translational Research in Cancer$3,102,433
P30 · FY2010 · CA
Translational Research in Cancer$3,102,433
P30 · FY2009 · CA
Translational Research in Cancer$3,065,902
P30 · FY2025 · CA